1.59800 EUR
0.002
0.13%
Last update Dec 17, 8:11 AM CET
Main market
Day range
1.59800
1.59800
Previous close
1.59600
Open
1.59800
Access this stock data via API
Subscribe
Innate Pharma S.A.
1.60
0.00
0.13%

Financials

Income statement

Fiscal date 2024 2023 2022 2021
Total reported revenue 12.6M 51.9M 49.6M 12.1M
Cost of revenue
Gross profit
Operating expense
Research & development 52.0M 56.0M 51.7M 47.0M
Selling general and admin 11.9M 11.7M 14.5M 16.0M
Other operating expenses 284K -3.2M -131K -3.1M
Operating income -51.6M -12.7M -16.4M -47.8M
Non operating interest income
Income 2.4M 3.2M 546K 327K
Expense 566K 640K 288K 312K
Other income expense 232K 2.6M -41.8M 2.3M
Pretax income -49.5M -7.6M -58.0M -45.5M
Tax provision 0 0 0 0
Net income -49.5M -7.6M -58.1M -52.8M
Basic EPS -0.6 -0.1 -0.7 -0.7
Diluted EPS -0.6 -0.1 -0.7 -0.7
Basic average shares 81.1M 84.1M 79.6M 79.5M
Diluted average shares 81.1M 84.1M 79.6M 79.5M
EBITDA -47.1M -4.4M 29.5M -42.9M
Net income from continuing op. -49.5M -7.6M -58.1M -52.8M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 51 minutes

19:08
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).